Home/Pipeline/Vaxine TB Vaccine

Vaxine TB Vaccine

Tuberculosis

PreclinicalActive

Key Facts

Indication

Tuberculosis

Phase

Preclinical

Status

Active

Company

About Vaxine

AI‑enhanced vaccine developer using the Advax™ adjuvant platform for infectious disease and immunotherapy.

View full company profile

Therapeutic Areas

Infectious Disease Oncology Allergy Neurology

Other Tuberculosis Drugs

Drug	Company	Phase	Status
Isoniazid Oral Solution, USP	CMP Pharma	Approved	Marketed
Tuberculosis Program	Fimbrion Therapeutics	Preclinical	Active
Undisclosed Program	Crestone	Preclinical	Active
Tuberculosis Diagnostic	GenEndeavor	Research/Exploratory	Active
TB Screening LFA	DiagMetrics	Development	Active
RGFields for Tuberculosis	Anapole Technologies	Pre-clinical	Active
Tuberculosis Nanobody	VicuTec Biologicals	Pre-clinical	Active
Not specified on provided pages	Cadila Pharmaceuticals	Commercial (World's First Claim)	Marketed
TB Diagnostic & Drug Discovery	Avesthagen	Research/Discovery	Active
ALF Platform	Senzo	Pre-clinical	Active
Satiro Tablets	KYORIN Pharmaceutical	Registration	Active (In-licensed for Japan)